InSitu Biologics, Inc, 2025-12-18
An SEC Form D private-offering notice from Oakdale, MN, a $8,000,000 filer-stated offering target in Biotech. Filed 2025-12-18. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Develops injectable, sustained release drug delivery technology for non-opioid, localized treatment of post-operative pain and, in early development, cancer.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Bim Bam Boo Inc., 2025-12-23, $2.5M, Minneapolis, MN
- Lexaria Bioscience Corp., 2025-12-19, $3.5M, Kelowna, BC, Canada
- Babbl Labs, Inc., 2025-12-23, $500K, Minneapois, MN
- NEONC TECHNOLOGIES HOLDINGS, INC., 2025-12-18, $1M, Calabasas, CA
- AristaVue Inc., 2025-12-22, $750K, Bloomington, MN
- Ceretype Neuromedicine, Inc., 2025-12-18, $400K, Cambridge, MA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.